Prospective multi-center dosimetry study of low-dose iodine-125 prostate brachytherapy performed after transurethral resection

Journal of Contemporary Brachytherapy

Volumn 5, Issue 2, 2013, Pages 63-69

  Salembier, Carl ^a   Rijnders, Alex ^a   Henry, Ann ^b   Niehoff, Peter ^c   Siebert, Frank André ^d   Hoskin, Peter ^e  

^a Europe Hospitals   (Belgium)

^b St James's Institute of Oncology   (United Kingdom)

^c UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^e MOUNT VERNON CANCER CENTRE   (United Kingdom)

Author keywords

Brachytherapy; Permanent seed implant; Prostate cancer; Transurethral resection; TURP

Indexed keywords

IODINE 125;

ARTICLE; BRACHYTHERAPY; DOSIMETRY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRACTICE GUIDELINE; PROSPECTIVE STUDY; PROSTATE CANCER; PROSTATE VOLUME; PROTOCOL COMPLIANCE; RADIATION DOSE; TRANSRECTAL ULTRASONOGRAPHY; TRANSURETHRAL RESECTION; TREATMENT PLANNING;

EID: 84882332953     PISSN: 1689832X     EISSN: None     Source Type: Journal    
DOI: 10.5114/jcb.2013.36174     Document Type: Article

References (19)

1. Nag S, Beyer D, Friedland J et al. American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. Int J Radiat Oncol Biol Phys 1999;44:789-799. (Pubitemid 29284127)
2. Davis BJ, Horwitz EM, Lee WR et al. American Brachytherapy Society consensus guidelines for transrectal ultrasoundguided permanent prostate brachytherapy. Brachytherapy 2012;11:6-19.
3. Ash D, Flynn A, Battermann J et al. ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer. Radiother Oncol 2000;57:315-321.
4. Blasko JC, Ragde H, Grimm PD. Transperineal ultrasoundguided implantation of the prostate: morbidity and complications. Scand J Urol Nephrol Suppl 1991;137:113-118.
5. Wallner K, Lee H, Wasserman S et al. Low risk of urinary incontinence following prostate brachytherapy in patients with a prior transurethral prostate resection. Int J Radiat Oncol Biol Phys 1997;37:565-569. (Pubitemid 27175311)
6. Stone NN, Ratnow ET, Stock RG. Prior transurethral resection does not increase morbidity following real-time ultrasoundguided prostate seed implantation. Tech Urol 2000;6:123-127. (Pubitemid 30227188)
7. Moran JM, Stutz MA, Gurel MH. Prostate brachytherapy can be performed in selected patients after transurethral resection of the prostate. Int J Radiat Oncol Biol Phys 2004;59:392-396. (Pubitemid 38622591)
8. Salembier C, Martens G, De Groote P et al. Prior transurethral resection of the prostate should not be a contra-indication for prostate seed brachytherapy. European Multidisciplinary Meeting on Urological Cancers, Barcelona 2009; November 27-29. Abstract P021-60.
9. Salembier C, Lavagnini P, Nickers P et al., on behalf of the PROBATE group of GEC ESTRO. Tumour and target volumes in permanent prostate brachytherapy: A supplement to the ESTRO/EAU/EORTC recommendations on prostate brachy - therapy. Radiother Oncol 2007;83:3-10. (Pubitemid 46527942)
10. McElveen T, Waterman F, Hayeon K et al. Factors predicting for urinary incontinence after prostate brachytherapy. Int J Radiat Oncol Biol Phys 2004;59:1395-1404. (Pubitemid 38954061)
11. Cesaretti JA, Stone NN, Stock MD. Does prior transurethral re section of the prostate compromise brachytherapy quality: a do simetry analysis. Int J Radiat Oncol Biol Phys 2004;60:648-653. (Pubitemid 39233487)
12. Cazzaniga LF, Marinoni MA, Bossi A et al. Interphysician variability in defining the planning target volume in the irradiation of prostate and seminal vesicles. Radiother Oncol 1998;47:293-296. (Pubitemid 28293651)
13. De Brabandere M, Haustermans K, Van Den Heuvel F et al. Prostate post-implant dosimetry: interobserver variability in seed localization, contouring and fusion. Radiother Oncol 2011;99:86-87.
14. Fiorino C, Reni M, Bolognesi A et al. Intra-en inter-observer variability in contouring prostate and seminal vesicles: implications for conformal treatment planning. Radiother Oncol 1998;47:285-292. (Pubitemid 28293650)
15. Gao Z, Wilkins D, Eapen L et al. A study of prostate delineation referenced against a gold standard created from the visible human data. Radiother Oncol 2007;85:239-246. (Pubitemid 350160996)
16. Matzinger O, Poortmans P, Giraud JY et al. Quality assurance in the 22991 EORTC ROG trial in localized prostate cancer: dummy run and individual case review. Radiother Oncol 2009;90:285-290.
17. Seddon B, Bidmead M, Wilson J et al. Target volume definition in conformal radiotherapy for prostate cancer: quality assurance in the MRC RT-01 trial. Radiother Oncol 2000;56:73-83. (Pubitemid 30408389)
18. Rosewall T, Kong V, Vespirini D et al. Prostate delineation using CT and MRI for radiotherapy patients with bilateral hip protheses. Radiother Oncol 2009;90:325-330.
19. Smith S, Wallner K, Merrick G et al. Interpretation of pre-versus postimplant TRUS images. Med Phys 2003;30:920-924. (Pubitemid 36578696)